Clinical trial
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer…
NCT00130533 · Spanish Breast Cancer Research Group, Other · Completed
Key facts
| NCT number | NCT00130533 |
|---|---|
| Title | Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients |
| Official title | Multicenter, Open-label, Randomized Phase III to Evaluate Efficacy of Maintenance Treatment With Capecitabine Following Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer Patients |
| Lead sponsor | Spanish Breast Cancer Research Group, Other |
| Collaborators | Hoffmann-La Roche Industry IBEROAMERICAN COALITION FOR BREAST ONCOLOGY RESEARCH (CIBOMA) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine |
| Enrollment | 876 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 17, 2017 |
| Completion | Feb 17, 2017 |
| First posted | Aug 15, 2005 |
| Last update posted | Mar 31, 2023 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: